Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Poseida Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 56 | 68 | +12 |
| Shares | 22.5M | 40.1M | +17.6M (+78.1%) |
| Value | $58.1M | $141.8M | +$83.7M (+144.1%) |
New holders (24)
Institutions that held Poseida Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (12)
Institutions that held Poseida Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 90,445 | $233.0K |
| State of Wisconsin Investment Board | 24,322 | $63.0K |
| State of Tennessee, Treasury Department | 18,705 | $48.0K |
| Delphia (USA) Inc. | 15,799 | $41.0K |
| Corton Capital Inc. | 14,978 | $39.0K |
| Acadian Asset Management LLC | 12,099 | $31.0K |
| Russell Investments Group, Ltd. | 8,421 | $21.0K |
| TD Waterhouse Canada Inc. | 1,500 | $3.75K |
| New York State Common Retirement Fund | 307 | $1.00K |
| Advisor Group Holdings, Inc. | 251 | $1.00K |
| Credit Suisse AG | 15 | $0 |
| Ellevest, Inc. | 7 | $0 |